Please assess the completion status of the following clinical trial:

Trial Title: Rosuvastatin Affecting Aortic Valve Endothelium

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: DEFINED_POPULATION
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Asymptomatic AS~* Normal ejection fraction~* Elevated LDL \>130 mg/dl~Exclusion Criteria:~* Echocardiographic evidence of rheumatic mitral valve disease,~* Previous statin therapy,~* Congenital heart disease (bicuspid aortic valve),~* Subaortic obstruction,~* Creatinine ≥ 2,0 mg/dl (to avoid the potential confounder of an elevated serum \[CaP04\]),~* Evidence of liver disease,~* Greater than mild aortic regurgitation and previous aortic valve surgery

- Gender: ALL
- Minimum Age: 50 Years
- Maximum Age: None
- Healthy Volunteers: t

Based on this trial design, predict the completion outcome and termination type (if applicable).